Overexpression and gene amplification of EGFR, HER2, and HER3 in biliary tract carcinomas, and the possibility for therapy with the HER2-targeting antibody pertuzumab

[1] Dixon E(2005)An aggressive surgical approach leads to improved survival in patients with gallbladder cancer: a 12-year study at a North American center Ann Surg 241 385-394

[2] Vollmer CM(2001)Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma Ann Surg 234 507-517

[3] Sahajpal A(2004)Outcomes after resection of cholangiocellular carcinoma Am J Surg 187 612-617

[4] Jarnagin WR(2003)Aggressive surgical resection for hilar-invasive and peripheral intrahepatic cholangiocarcinoma World J Surg 27 289-293

[5] Fong Y(1992)Carcinoma of the gallbladder. Histologic types, stage of disease, grade, and survival rates Cancer 70 1493-1497

[6] DeMatteo RP(2010)Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer N Engl J Med 362 1273-1281

[7] Huang JL(2013)Randomized phase II study of gemcitabine plus S-1 versus S-1 in advanced biliary tract cancer: a Japan Clinical Oncology Group trial (JCOG 0805) Cancer Sci 104 1211-1216

[8] Biehl TR(1996)Biliary proliferation and adaptation in furan-induced rat liver injury and carcinogenesis Toxicol Pathol 24 90-99

[9] Lee FT(2005)Cholangiocarcinoma: molecular targeting strategies for chemoprevention and therapy Hepatology 41 5-15

[10] Nakagohri T(2002)Cyclooxygenase-2 and ERBB-2 in cholangiocarcinoma: potential therapeutic targets Semin Liver Dis 22 303-313

[1] Dixon E(2005)An aggressive surgical approach leads to improved survival in patients with gallbladder cancer: a 12-year study at a North American center Ann Surg 241 385-394

[2] Vollmer CM(2001)Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma Ann Surg 234 507-517

[3] Sahajpal A(2004)Outcomes after resection of cholangiocellular carcinoma Am J Surg 187 612-617

[4] Jarnagin WR(2003)Aggressive surgical resection for hilar-invasive and peripheral intrahepatic cholangiocarcinoma World J Surg 27 289-293

[5] Fong Y(1992)Carcinoma of the gallbladder. Histologic types, stage of disease, grade, and survival rates Cancer 70 1493-1497

[6] DeMatteo RP(2010)Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer N Engl J Med 362 1273-1281

[7] Huang JL(2013)Randomized phase II study of gemcitabine plus S-1 versus S-1 in advanced biliary tract cancer: a Japan Clinical Oncology Group trial (JCOG 0805) Cancer Sci 104 1211-1216

[8] Biehl TR(1996)Biliary proliferation and adaptation in furan-induced rat liver injury and carcinogenesis Toxicol Pathol 24 90-99

[9] Lee FT(2005)Cholangiocarcinoma: molecular targeting strategies for chemoprevention and therapy Hepatology 41 5-15

[10] Nakagohri T(2002)Cyclooxygenase-2 and ERBB-2 in cholangiocarcinoma: potential therapeutic targets Semin Liver Dis 22 303-313